3rd Annual McGill Global Surgery Conference, May 17th 2014 at McGill University’s McIntyre Building: Palmer Theatre
The 3rd Annual McGill Global Surgery Conference is an interdisciplinary conference focused on the field of surgery in global health, which is happening on Saturday, May 17th 2014 at McGill University’s McIntyre building: Palmer Theatre.
Registration is now open and payable via Paypal.
The Faculty of Medicine's Interprofessional Global Health Course is hosting an exclusive documentary screening and meet-n-greet with Emmy-award winning documentary filmmaker Lisa Russell! The documentary that will be screened is called Poder, "A short narrative film based on the real life story of two indigenous girls in the highlands of Guatemala who challenged their elected officials to provide more services to adolescents in their community." Poder has not yet been released, so the McGill audience will be the first to see it!
When: Tuesday March 25th, 2014 8pm-9:30pm
It has been estimated that over 1 billion people worldwide live without access to health care. Organizations such as Partners In Health work relentlessly to improve access to primary and secondary health care to those who need it most. Despite modern medical advancements and the ability to treat people in remote parts of the world, millions of people are still left without hospitals, without doctors, and without treatment. Join the movement today to reverse these trends and enter the discussion by attending the conference Whatever It Takes.
Join us at the inaugural McGill “Global is Local” Conference, Wednesday, May 7, 2014, hosted by McGill Global Health Programs! Still a few seats left!
Mark Your Calendars:
McGill “Global is Local” Conference
Join us at the inaugural McGill “Global is Local” Conference, Wednesday, May 7, 2014, hosted by McGill Global Health Programs!
This event will serve as an opportunity for the plethora of University researchers, academics, clinicians and students involved in Global Health activities to discuss, network and highlight their respective programs and projects.
Gender, disability and global health: The rights of girls and women with disabilities - 19 Feb 2014 12:00 - Chancellor Day Hall
Gender, disability and global health: The rights of girls and women with disabilities
19 Feb 2014 12:00 to 14:00
Chancellor Day Hall : Stephen Scott Seminar Room (OCDH 16), 3644 rue Peel Montreal Quebec Canada , H3A 1W9
CFHI Announces New Uganda Community Health Programs
— Live Program Information Webinar: January 21st —
Starting in April 2014 CFHI begins community-based programs in it's newest partner country, Uganda.
The 17th World Congress of Food Science and Technology will be hosted in Montréal on August 17th -21st, 2014.
The congress theme "Research that Resonates" was carefully selected to reflect how understanding the successful commercialization of innovation is more important today than ever before.
Child Family Health International www.cfhi.org
WINTER 2013/2014 GLOBAL HEALTH PROGRAM OPENINGS
Live Program Information Webinar: December 16th
CFHI PROGRAM OPENINGS: CFHI is currently accepting applications for its global health programs through 2015, and still has last minute spots left for December/January 201
Dr. Dan Deckelbaum participated at the annual meeting of the College of Surgeons of Central, Eastern and Southern Africa (COSECSA)
Dr. Dan Deckelbaum, GHP Director, participated at the annual meeting of the College of Surgeons of Central, Eastern and Southern Africa (COSECSA). Pictured are Dr. Lando Ruhungande, senior surgical resident at the National University of Rwanda, and Dr. Deckelbaum after Lando's presentation of a collaborative research project between the Centre for Global Surgery at the MUHC and the National University of Rwanda.
Incentives for Global Health's (IGH) mission is to increase access to essential medicines through our flagship proposal, the Health Impact Fund (HIF). Millions of people suffer and die each year from neglected diseases because pharmaceutical companies sell their patented drugs at hugely marked-up prices. These companies are incentivized by the international intellectual property system to develop drugs for ailments that affect primarily affluent people who can afford these exorbitant drugs.